Abstract
The relationship between time-dependent inactivation (TDI) and IC50 is examined using a consolidated method for evaluating CYP450 inhibition during drug discovery. An IC50 fold-shift of > 1.5 indicated significant TDI potency. Further, the “shifted IC50” could be used to estimate, the KI and TDI potency ratio kinact/KI to within 2-fold in most cases.